| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G/A
| Dexcel Pharma Technologies Ltd. reports a 14.2% stake in Roivant Sciences Ltd. |
| 04/26/2022 |
4
| Dexcel Pharma Technologies Ltd. (10% Owner) has filed a Form 4 on Roivant Sciences Ltd.|
Txns:
| Bought 31,685 shares
@ $3.8289, valued at
$121.3k
Bought 8,600 shares
@ $3.9111, valued at
$33.6k
|
|
| 02/10/2022 |
SC 13G
| Dexcel Pharma Technologies Ltd. reports a 14.3% stake in Roivant Sciences Ltd. |
| 10/01/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/15/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 06/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 03/25/2020 |
SC 13G
| Dexcel Pharma Technologies Ltd. reports a 10% stake in Protalix BioTherapeutics, Inc. |
| 02/25/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/05/2020 |
SC 13G/A
| Dexcel Pharma Technologies Ltd. reports a 8.1% stake in Intec Pharma Ltd. |
| 02/04/2020 |
4
| Dexcel Pharma Technologies Ltd. (10% Owner) has filed a Form 4 on Intec Pharma Ltd.|
Txns:
| Sold 725,951 shares
@ $0.309, valued at
$224.3k
Sold 80,000 shares
@ $0.318, valued at
$25.4k
Sold 110,000 shares
@ $0.29, valued at
$31.9k
|
|
| 07/12/2019 |
4
| Dexxon Holdings Ltd. (See remarks) has filed a Form 4 on Axovant Gene Therapies Ltd. |
| 07/12/2019 |
4
| Dexxon Holdings Ltd. (See remarks) has filed a Form 4 on Myovant Sciences Ltd. |
| 07/12/2019 |
4
| Dexxon Holdings Ltd. (See remarks) has filed a Form 4 on Arbutus Biopharma Corp |
| 07/12/2019 |
4
| Dexxon Holdings Ltd. (See remarks) has filed a Form 4 on Urovant Sciences Ltd. |
| 06/19/2019 |
4
| Dexxon Holdings Ltd. (10% Owner) has filed a Form 4 on Urovant Sciences Ltd.|
Txns:
| Bought 6,541 shares
@ $8.5346, valued at
$55.8k
Bought 6,706 shares
@ $8.2107, valued at
$55.1k
Bought 4,957 shares
@ $8.1693, valued at
$40.5k
|
|
| 06/14/2019 |
4
| Dexxon Holdings Ltd. (10% Owner) has filed a Form 4 on Urovant Sciences Ltd.|
Txns:
| Bought 7,500 shares
@ $8.2992, valued at
$62.2k
Bought 7,367 shares
@ $7.9466, valued at
$58.5k
Bought 7,144 shares
@ $7.9107, valued at
$56.5k
|
|
| 06/11/2019 |
4
| Dexxon Holdings Ltd. (10% Owner) has filed a Form 4 on Urovant Sciences Ltd.|
Txns:
| Bought 6,649 shares
@ $7.965, valued at
$53k
Bought 7,500 shares
@ $8.3459, valued at
$62.6k
Bought 7,189 shares
@ $8.5817, valued at
$61.7k
|
|
| 06/06/2019 |
4
| Dexxon Holdings Ltd. (10% Owner) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Bought 2,424,242 shares
@ $8.25, valued at
$20M
|
|
| 06/06/2019 |
4
| Dexxon Holdings Ltd. (10% Owner) has filed a Form 4 on Urovant Sciences Ltd.|
Txns:
| Bought 7,500 shares
@ $7.5881, valued at
$56.9k
Bought 6,540 shares
@ $8.015, valued at
$52.4k
Bought 7,082 shares
@ $7.9951, valued at
$56.6k
|
|
| 06/03/2019 |
4
| Dexxon Holdings Ltd. (10% Owner) has filed a Form 4 on Urovant Sciences Ltd.|
Txns:
| Bought 6,951 shares
@ $7.9726, valued at
$55.4k
Bought 300 shares
@ $8.9066, valued at
$2.7k
Bought 5,071 shares
@ $7.6991, valued at
$39k
Bought 5,424 shares
@ $7.7092, valued at
$41.8k
|
|
| 05/29/2019 |
4
| Dexxon Holdings Ltd. (10% Owner) has filed a Form 4 on Urovant Sciences Ltd.|
Txns:
| Bought 3,796 shares
@ $7.7011, valued at
$29.2k
Bought 3,807 shares
@ $7.6818, valued at
$29.2k
Bought 6,882 shares
@ $7.5535, valued at
$52k
|
|
| 05/28/2019 |
4
| Dexxon Holdings Ltd. (10% Owner) has filed a Form 4 on Urovant Sciences Ltd.|
Txns:
| Bought 5,033 shares
@ $8.0584, valued at
$40.6k
Bought 4,802 shares
@ $7.7576, valued at
$37.3k
|
|
| 05/23/2019 |
4
| Dexxon Holdings Ltd. (10% Owner) has filed a Form 4 on Urovant Sciences Ltd.|
Txns:
| Bought 9,995 shares
@ $8.5151, valued at
$85.1k
|
|
| 05/22/2019 |
4
| Dexxon Holdings Ltd. (10% Owner) has filed a Form 4 on Urovant Sciences Ltd.|
Txns:
| Bought 8,285 shares
@ $7.9833, valued at
$66.1k
Bought 1,715 shares
@ $8.3867, valued at
$14.4k
|
|
| 05/20/2019 |
4
| Dexxon Holdings Ltd. (10% Owner) has filed a Form 4 on Urovant Sciences Ltd.|
Txns:
| Bought 5,408 shares
@ $6.7896, valued at
$36.7k
Bought 6,200 shares
@ $7.3615, valued at
$45.6k
|
|
| 03/19/2019 |
4
| Dexxon Holdings Ltd. (10% Owner) has filed a Form 4 on Axovant Sciences Ltd.|
Txns:
| Bought 6,666,667 shares
@ $1.5, valued at
$10M
|
|
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/20/2018 |
4
| Dexxon Holdings Ltd. (10% Owner) has filed a Form 4 on Axovant Sciences Ltd.|
Txns:
| Bought 10,000,000 shares
@ $1, valued at
$10M
|
|
| 10/03/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/27/2018 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 09/26/2018 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|